The fab and fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling 1 1Edited by R. Huber
“…Molecular modeling predicts that Cys 133 will fold into the proximity of the terminal cysteine of the L chain. These same studies showed that HL disulfide bond formation could be restored to IgA2m (1) No crystal structure exists for IgA; however, molecular models of IgA1 have been published (15,16). In these models, displacement of the C H 2 domains was required to accommodate the glycosylation and disulfide-bonding pattern leading to steric crowding around the N-terminal region of the hinge compared with IgG1.…”
In humans, there are two subclasses of IgA, IgA1 and IgA2, with IgA2 existing as three allotypes, IgA2m(1), IgA2m(2) and IgA2(n). In IgA1, Cys133 in CH1 forms the disulfide bond to the L chain. Our previous studies indicated that in IgA2 lacking Cys133, a disulfide bond forms between the α-chain and the L chain when Cys220 is followed by Arg221, but not when Cys220 is followed by Pro221, suggesting that the Cys in CH1 might be involved in disulfide bonding to the L chain. However, here we show that covalent assembly of the H and L chains in IgA2(n) requires hinge-proximal Cys241 and Cys242 in CH2 and not Cys196 or Cys220 in CH1. Using pulse-chase experiments, we have demonstrated that wild-type IgA2(n) with Arg221 and Cys241 and Cys242 assembles through a disulfide-bonded HL intermediate. In contrast, the major intermediate for IgA2 m(1) with Pro221 assembly was H2 even though both Cys241 and Cys242 were present. Only a small fraction of IgA2 m(1) assembles through disulfide-bonded HL. Overall, our studies indicate that for IgA2 covalent assembly of the H and L chains requires the hinge-proximal cysteines in CH2 and that the structure of CH1 influences the efficiency with which this covalent bond forms.
“…Molecular modeling predicts that Cys 133 will fold into the proximity of the terminal cysteine of the L chain. These same studies showed that HL disulfide bond formation could be restored to IgA2m (1) No crystal structure exists for IgA; however, molecular models of IgA1 have been published (15,16). In these models, displacement of the C H 2 domains was required to accommodate the glycosylation and disulfide-bonding pattern leading to steric crowding around the N-terminal region of the hinge compared with IgG1.…”
In humans, there are two subclasses of IgA, IgA1 and IgA2, with IgA2 existing as three allotypes, IgA2m(1), IgA2m(2) and IgA2(n). In IgA1, Cys133 in CH1 forms the disulfide bond to the L chain. Our previous studies indicated that in IgA2 lacking Cys133, a disulfide bond forms between the α-chain and the L chain when Cys220 is followed by Arg221, but not when Cys220 is followed by Pro221, suggesting that the Cys in CH1 might be involved in disulfide bonding to the L chain. However, here we show that covalent assembly of the H and L chains in IgA2(n) requires hinge-proximal Cys241 and Cys242 in CH2 and not Cys196 or Cys220 in CH1. Using pulse-chase experiments, we have demonstrated that wild-type IgA2(n) with Arg221 and Cys241 and Cys242 assembles through a disulfide-bonded HL intermediate. In contrast, the major intermediate for IgA2 m(1) with Pro221 assembly was H2 even though both Cys241 and Cys242 were present. Only a small fraction of IgA2 m(1) assembles through disulfide-bonded HL. Overall, our studies indicate that for IgA2 covalent assembly of the H and L chains requires the hinge-proximal cysteines in CH2 and that the structure of CH1 influences the efficiency with which this covalent bond forms.
“…Because hydration shells are visible by x-rays, a hydration shell corresponding to 0.3 g of water/g of protein was created using HYPRO (31), giving an optimal total of 1607 spheres. The x-ray scattering curve I(Q) was calculated using the Debye equation adapted to spheres (16,32). Steric overlap between the Fab and Fc regions was assessed using the number of spheres n in each model, where models showing less than 95% of the required total of 1607 spheres (x-ray) or 1220 spheres (neutrons) were discarded.…”
Background:The human IgG1 antibody subclass is the most abundant one and is widely used in therapeutic applications. Results: Ultracentrifugation and x-ray/neutron scattering, together with atomistic modeling, revealed asymmetric concentration-independent IgG1 solution structures.
Conclusion:The complement and receptor Fc binding sites are not hindered by the Fab regions, explaining its full activity. Significance: These solution structures clarify IgG1 activity and its therapeutic applications.
“…6,7,9,45,46 The model of intact IgA1 was generated from published crystal and solution structures of IgA1. 47,48 N-and Oglycans were modeled using the GlyProt server and related databases (http://www. glycosciences.de), based on observed IgA1 glycoforms.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.